Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin in Patients With Urinary Calculi
NCT01539265Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silodosin in urinary calculus, sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
silodosin
03
Conditions
urinary calculus
Beyond the preview
Go deeper on NCT01539265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01539265.